Home Journals Subjects About My LA Reviewers Authors News Submit
.
(close)

(Ctrl-click to select multiple journals)


How should we address you?

Your email address


Enter the three character code
Visual CAPTCHA
Privacy Statement

Cardiovascular disorders

Get Updates

Cardiovascular disorders research articles, Cardiovascular disorders research article, Cardiovascular disorders journals, Cardiovascular disorders journal, Cardiovascular disorders articles, Research on Breast cancer, Cardiovascular disorders



Sign up for free journal updates
How should we address you?
Your email address
Enter the three character code
Visual CAPTCHA

peer reviewed open access journals 80




Latest news
  • Open access articles published in December
  • - 04/Jan/2010
  • November Pubmed visibility statistics
  • - 09/Dec/2009
  • Perspectives in Medicinal Chemistry Pubmed visibility statistics
  • - 09/Dec/2009
  • Gene Regulation and Systems Biology Pubmed visibility statistics
  • - 09/Dec/2009
  • Cancer Informatics Pubmed visibility statistics
  • - 09/Dec/2009
  • Biomarker Insights Pubmed visibility statistics
  • - 09/Dec/2009
  • Bioinformatics and Biology Insights Pubmed visibility statistics
  • - 09/Dec/2009
  • Analytical Chemistry Insights Pubmed visibility statistics
  • - 09/Dec/2009
  • Evolutionary Bioinformatics Pubmed visibility statistics
  • - 09/Dec/2009
  • 2010 special issues
  • - 07/Dec/2009
  • Proposals invited for Translational Oncogenomics special issue
  • - 07/Dec/2009
  • Proposals invited for Signal Transduction Insights special issue
  • - 07/Dec/2009
  • Proposals invited for Rehabilitation Process and Outcome special issue
  • - 07/Dec/2009
  • Proposals invited for Primary Prevention Insights special issue
  • - 07/Dec/2009
  • Proposals invited for Perspectives in Medicinal Chemistry special issue
  • - 07/Dec/2009
  • Proposals invited for Palliative Care: Research and Treatment special issue
  • - 07/Dec/2009
  • Proposals invited for Immunotherapy Insights special issue
  • - 07/Dec/2009
  • Proposals invited for Human Parasitic Diseases special issue
  • - 07/Dec/2009
  • Proposals invited for Healthy Aging and Clinical Care in the Elderly special issue
  • - 07/Dec/2009
  • Proposals invited for Genomics Insights special issue
  • - 07/Dec/2009
  • Proposals invited for Genetics and Epigenetics special issue
  • - 07/Dec/2009
  • Proposals invited for Environmental Health Insights special issue
  • - 04/Dec/2009
  • Proposals invited for Cell and Tissue Transplantation and Therapy special issue
  • - 04/Dec/2009
  • Proposals invited for Bone and Tissue Regeneration Insights special issue
  • - 04/Dec/2009

Latest pictures




Latest articles

Most read articles


(previous 30 days)Site updates
19
Articles published:
1
Comments:
25
Blog entries:
Get Updates
Get Updates
Abstract
Full-text PDF

Acute Coronary Syndrome in Pregnancy     (08/Dec/2009)


Acute coronary syndrome (ACS) in pregnancy has traditionally been considered to be a rare event, but the combination of normal physiological changes of pregnancy and more prevalent cardiovascular risk factors are increasing its incidence in this population. The present report describes a 39 year-old woman that is seven weeks pregnant...


Abstract
Full-text PDF

Osler-Weber-Rendu (OWR) Disease and Heart Failure     (25/Nov/2009)


OWR is a genetic disease, transmitted as an autosomal dominant disorder characterized by arteriovenous malformations pre-dominantly involving the mucocutaneous epithelium. One of the significant complications is the development of arteriovenous fistulas in different organs like the liver and brain. One of the rarest complications of this arteriovenous conduit is a...


Abstract
Full-text PDF

Doty’s Method (Two Sinus Reconstructions) of Supravalvular Aortic Stenosis in Williams’s Syndrome     (24/Nov/2009)


We experienced a successful surgical Williams’s syndrome case of extended aortoplasty by means of Doty’s method (two sinus reconstructions) for congenital supravalvular aortic stenosis. Case was 29-year-old woman, who had no complaint except heart murmur and dyspnea. The retrograde aortography and Digital Subtraction Angiography (DSA) demonstrated localized stenosis just above...


Article: Safety and Efficacy of Ivabradine in the Management of Stable Angina Pectoris
Full-text PDFAbstract

Safety and Efficacy of Ivabradine in the Management of Stable Angina Pectoris     (24/Nov/2009)


The first selective If current inhibitor, ivabradine, lowers heart rate (HR) at rest and during exercise with no vasomotor, negative inotropic, or negative lusitropic effects. Given that elevated resting HR is a key factor in the onset of myocardial ischemia and a strong independent predictor of cardiovascular outcomes, ivabradine provides new therapeutic prospects in coronary artery disease (CAD). Its selective HR-lowering action has proven anti-ischemic and anti-anginal efficacy, and ivabradine is currently indicated for the...


Abstract
Full-text PDF

Effects of Nebivolol on Endothelial Function and Exercise Parameters in Patients with Slow Coronary Flow     (03/Nov/2009)


Objective: Earlier studies have reported that a decrease in exercise capacity might indicate endothelial dysfunction. However, the effects of improvement of endothelial functions on exercise capacity have not been evaluated. The aim of the present study is to investigate the effects of nebivolol on flow-mediated dilatation (FMD), and on the...


Abstract
Full-text PDF

The Impact of Obesity on Adverse Cardiovascular Outcomes in the General Population and in Patients with Type 2 Diabetes     (28/Oct/2009)


Objectives: There is an established causal link between obesity and cardiovascular outcomes. The aim of this review was to determine whether an independent relationship exists between anthropometric measurements of weight (typically body mass index [BMI]) and cardiovascular outcomes (e.g. angina, myocardial infarction, congestive heart failure, stroke, and mortality due to...


Abstract
Full-text PDF

Fixed-dose Combination Therapy in Hypertension: Focus on Fixed-dose Combination of Amlodipine and Valsartan (Exforge®)     (19/Oct/2009)


Hypertension is the leading cause of disability and cardiovascular mortality world-wide. Approximately one-third of the US adult population and over a billion people world-wide have hypertension. Despite increased awareness of hypertension and availability of many effective antihypertensive agents, only one third of patients achieve their target blood pressure (BP). All...


Abstract
Full-text PDF

Pitavastatin in the Management of Hypercholesterolemia     (13/Oct/2009)


Pitavastatin is an HMG-CoA reductase inhibitor that significantly reduces the plasma levels of total cholesterol, LDL-C and triglycerides, while also causing modest elevation of the plasma high-density cholesterol (HDL-C) level. This statin is minimally metabolized by the cytochrome P-450 (CYP) isozymes; it is glucuronized and converted to the inactive lactone...


Abstract
Full-text PDF

Left Ventricular Rupture Post Mitral Valve Replacement     (23/Sep/2009)


Prevention is better than cure best applies here. As per many authors, posterior leaflet chordae preservation prevent Left ventricular rupture (LVR) and preserve LV geometry. We are presenting here 5 types of left ventricular rupture (LVR) post Mitral valve replacement (MVR) with different methods to repair with the advantages and...


Abstract
Full-text PDF

Good News from Aliskiren?     (17/Sep/2009)


The renin-angiotensin system can be inhibited through inhibition of angiotensin I generation from angiotensinogen by direct renin inhibitors, inhibition of angiotensin II generation from angiotensin I by angiotensin-converting enzyme inhibitors and by direct inhibition of the action of angiotensin II receptor level. Aliskiren, the first direct renin inhibitor to reach...


Abstract
Full-text PDF

Stress Cardiomyopathy (Takotsubo Cardiomyopathy)     (17/Sep/2009)


Background: Due to the rise in the number of reports of stress cardiomyopathy in the literature, awareness of this condition is increasing. Although different names have been used to describe this condition, the similarities in clinical, electrocardiographic, echocardiographic, and angiographic features suggest that they represent the same spectrum of diseases...


Abstract
Full-text PDF

Aliskiren for the Treatment of Hypertension: An Update     (15/Sep/2009)


Hypertension can lead to significant morbidity and mortality, and requires lifestyle modifications with or without drug therapy to achieve target blood pressure control. Various classes of anti-hypertensive medications are available to healthcare providers. Choice of medications is based not only on efficacy but also tolerability and cost. Aliskiren is the...


Abstract
Full-text PDF

Antiplatelet Resistance - Does it Exist and How to Measure it?     (03/Sep/2009)


Aspirin and clopidogrel are the most commonly used antiplatelet agents in patients with coronary artery disease. The existence of resistance to these agents has been a controversial issue and new drugs are being developed to overcome this problem. Laboratory tests, which can identify resistance and correlate this with clinical outcome,...


Abstract
Full-text PDF

Reduction in Risk of Myocardial Infarction, Stroke, and Death from Cardiovascular Causes. Focus on Rampiril     (31/Aug/2009)


Several clinical studies demonstrate a beneficial role of angiotensin-converting enzyme (ACE) inhibitors in patients with myocardial infarction, hypertension and diabetes mellitus. This review focuses on the effects of ramipril, a weak inhibitor of ACE that is rapidly hydrolyzed to ramiprilat, an active metabolite. The Heart Outcome Prevention Evaluation (HOPE) study...


Abstract
Full-text PDF

Cardiotoxicity of Oral Methadone as an Analgesic - Recommendations for Safe Use     (31/Aug/2009)


Once used only as third-line therapy in the management of chronic pain states, methadone is now being used as first- and second-line therapy. Most risks and the stigma associated with methadone use have been known for years. Only over the past decade or so have the unique pharmacokinetic-pharmacodynamic properties and...


Abstract
Full-text PDF

Safety and Efficacy of Eplerenone in the Management of Essential Hypertension     (25/Aug/2009)


Suppression of the Renin-Angiotensin-Aldosterone system (RAAS) is an established intervention in the management of cardiovascular disease. Large, randomized controlled trials have provided a sound evidence base for the use of mineralocorticoid receptor antagonists to block the end product of the RAAS in the treatment of heart failure. However, the place...


Abstract
Full-text PDF

Clopidogrel Bisulfate: A Review of its Use in the Management of Acute Coronary Syndrome     (07/Aug/2009)


Antiplatelet therapy is the cornerstone in the modern therapy of patients with acute coronary syndromes (ACS), because of the unique role of platelets in coronary thrombosis. Clopidogrel in combination with aspirin is the current “gold standard” for reducing cardiovascular events in such patients, providing a synergistic platelet inhibition through different...


Abstract
Full-text PDF

Management Options in Chronic Stable Angina Pectoris: Focus on Ranolazine     (31/Jul/2009)


Chronic stable angina pectoris results from a fixed coronary arterial obstruction causing an imbalance between myocardial oxygen supply and demand. Current therapy aims to reduce cardiovascular events (vasculoprotective) thereby improving survival, and/or relieve ischemic symptoms (antianginal) thereby improving the quality of life. Vasculoprotective therapy consists of lifestyle modification, antiplatelet agents,...


Abstract
Full-text PDF

Safety and Efficacy of the bi-Sulfydryl ACE-Inhibitor Zofenopril in the Management of Cardiovascular Disease     (15/Jul/2009)


In the 1970s, pharmacological therapy interrupting the renin-angiotensin system was considered beneficial for patients with high-renin hypertension. Angiotensin-converting enzyme (ACE) inhibitors proved to be effective not only in patients with high renin and elevated blood pressure, but also in many hypertensive patients with normal levels of plasma renin activity. ACE...


Abstract
Full-text PDF

Introductory Editorial      (09/Jul/2009)


Garry Walsh Reader in Inflammation and Immunity, University of Aberdeen Scotland, United Kingdom.


Abstract
Full-text PDF

Introductory Editorial      (09/Jul/2009)


Garry Walsh Reader in Inflammation and Immunity, University of Aberdeen Scotland, United Kingdom.


Abstract
Full-text PDF

Single Sevikar®: Combination Therapy for the Treatment of Hypertension     (01/Jul/2009)


Hypertension is one of the most important modifiable risk factor for cardiovascular morbidity and mortality and is highly prevalent. Recent guidelines and advisory statements have recommended lower thresholds and goals for patients with hypertension. However, approximately two-thirds of hypertensive patients do not achieve the goals. Poor adherence to anti-hypertensive medication...


Abstract
Full-text PDF

HMGCoA-Reductase Inhibitors in Dementia: Benefit or Harm     (12/Jun/2009)


Dementia is a syndrome characterized by a decline in cognitive function. Alzheimer’s disease and cerebro-vascular disease are the most common causes of dementia. Many factors (genetic, life style, vascular etc.) appear to play some role in the development of dementia. Statins significantly reduce vascular disease and could reduce cognitive impairment...


Article: Assessment of Myocardial Scar; Comparison Between <sup>18</sup>F-FDG PET, CMR and <sup>99</sup>Tc-Sestamibi
Full-text PDFAbstract

Assessment of Myocardial Scar; Comparison Between 18F-FDG PET, CMR and 99Tc-Sestamibi     (08/Jun/2009)


Objective: Patients with heart failure and ischaemic heart disease may obtain benefit from revascularisation if viable dysfunctional myocardium is present. Such patients have an increased operative risk, so it is important to ensure that viability is correctly identified. In this study, we have compared the utility of 3 imaging modalities to detect myocardial scar. Design: Prospective, descriptive study. Setting: Tertiary cardiac centre. Patients: 35 patients (29 male, average age 70 years) with coronary artery disease and symptoms of...


Abstract
Full-text PDF

Pharmacotherapy of Excessive Sleepiness: Focus on Armodafinil     (28/May/2009)


Excessive sleepiness (ES) is responsible for significant morbidity and mortality due to its association with cardiovascular disease, cognitive impairment, and occupational and transport accidents. ES is also detrimental to patients’ quality of life, as it affects work and academic performance, social interactions, and personal relationships. Armodafinil is the R-enantiomer of...


Abstract
Full-text PDF

Circulating CD34+ Cell Count is Associated with Extent of Subclinical Atherosclerosis in Asymptomatic Amish Men, Independent of 10-Year Framingham Risk     (27/May/2009)


Background: Bone-marrow derived progenitor cells (PCs) may play a role in maintaining vascular health by actively repairing damaged endothelium. The purpose of this study in asymptomatic Old Order Amish men (n = 90) without hyper- tension or diabetes was to determine if PC count, as determined by CD34+ cell count...


Abstract
Full-text PDF

Pathway Analysis of Differentially Expressed Genes in Patients with Acute Aortic Dissection     (06/May/2009)


Background: Acute aortic dissection (AAD) is a life-threatening condition with high mortality and a relatively unclarified pathophysiological mechanism. Although differentially expressed genes in AAD have been recognized, interactions between these genes remain poorly defined. This study was conducted to gain a better understanding of the molecular mechanisms underlying AAD and...


Abstract
Full-text PDF

Hypertension Management and End Organ Protection: Focus on Aliskiren     (01/May/2009)


Toshio Imanishi, Hiroto Tsujioka and Takashi AkasakaDepartment of Cardiovascular Medicine, Wakayama Medical University. 811-1, Kimiidera, Wakayama City, Wakayama, Japan.AbstractThe renin-angiotensin system (RAS) activity is a key factor in the pathophysiology and development of hypertension, atherosclerosis, heart failure, and renal disease. It is unclear whether angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-receptor blockers...


Abstract
Full-text PDF

Efficacy and safety of fixed-dose Lercanidipine-Enalapril for the treatment of hypertension     (20/Apr/2009)


Christos Chatzikyrkou, Hermann Haller and Jan MenneDepartment of Nephrology, Hannover Medical School, Germany.AbstractHypertension is the most important preventable cause of premature death in the developed countries, and the benefits of antihypertensive drugs regarding cardiovascular morbidity and mortality are well established. Nevertheless, adequate control is achieved only in the minority of...


Abstract
Full-text PDF

Improvement of Young and Elderly Patient’s Knowledge of Heart Failure After an Educational Session     (20/Apr/2009)


Jérôme Roncalli1,2, Laurence Perez1, Atul Pathak1,3, Laure Spinazze1, Sandrine Mazon1, Olivier Lairez1, Daniel Curnier2, Joëlle Fourcade1, Meyer Elbaz1, Didier Carrié1, Jacques Puel1,4, Jean-Marie Fauvel1 and Michel Galinier1,21Rangueil University Hospital, Department of Cardiology and Heart Failure Educational Centre (Centre d’ Education pour Patient Insuffisant Cardiaque (CEPIC)), Toulouse, France. 2INSERM U858-I2MR, Hôpital...